MedPath

World Hip Trauma Evaluation - LIT: an investigation in people 60 years and over with a hip fracture to determine whether an infusion of a local anaesthetic (lidocaine) can reduce symptoms of delirium in the first five days after hip fracture surgery

Not Applicable
Conditions
Hip fracture
Musculoskeletal Diseases
Fracture of neck of femur
Registration Number
ISRCTN10817487
Lead Sponsor
niversity of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
416
Inclusion Criteria

Platform inclusion criteria:
1. Aged =60 years
2. Diagnosed with a hip fracture that in the opinion of the treating surgeon may benefit from surgical treatment

No additional specific inclusion criteria for LIT.

Exclusion Criteria

Platform exclusion criteria.
1. Previous participation in the same randomised comparison
2. A second hip fracture (other side) while the patient is still enrolled in the Platform following their first hip fracture

Additional specific exclusion criteria for LIT:
1. Body weight estimated to be <40 kg or >100 kg
2. Known subdural haematoma
3. Known allergy to local anaesthetics
4. Severely impaired renal (eGFR <30 ml.min-1) or hepatic (based on clinical history) function
5. Patient has specific contraindications to lidocaine:
5.1. All grades of atrioventricular block; severe myocardial depression; sino-atrial disorders
5.2. Acute porphyria
5. 3. Current congestive cardiac failure
6. Concurrent participation in a clinical trial of a medicinal product or recent participation within 5 half-lives of the last dose of medicinal product
7. Local anaesthetic nerve block administered within the previous 6 hours
8. Known serum albumin <30 g/l

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak post-operative delirium as measured by the Memorial Delirium Assessment Scale (MDAS) at days 1-5 after surgery.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath